Literature DB >> 21739392

Subacute combined degeneration caused by nitrous oxide intoxication: case reports.

Ru-Jen Lin1, Hoi-Fong Chen, Yang-Chyuan Chang, Jen-Jen Su.   

Abstract

PURPOSE: Case reports with a comprehensive review of the current literature concerning subacute combined degeneration induced by nitrous oxide inhalation. A differential diagnosis should be considered when young patients present with progressive myelopathy because that the misuse of nitrous oxide has potentially serious outcomes. CASES REPORT: Three young patients aged from 18 to 24, one male and two females, were diagnosed with progressive ascending numbness in four limbs or both legs and ataxia. They all had been inhaling nitrous oxide from whipped-cream containers for several months. A cervicothoracic magnetic resonance imaging scan revealed long segmental hyperintensity changes at the posterior column of the spinal cord. Serological examination showed a low level of vitamin B12. Subacute combined degeneration of the spinal cord was diagnosed and the etiology was considered related to nitrous oxide misuse. Their neurological status, neuroimage, and neurophysiologic condition improved after vitamin B12 supplementation and cessation of nitrous oxide inhalation.
CONCLUSION: Iatrogenic usage of nitrous oxide apparently resulted in subacute combined degeneration in our three patients. Recently, nitrous oxide misuse has increased among young people. Subacute combined degeneration of the spinal cord should be considered as a possible outcome of such abuse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739392

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  13 in total

1.  Spine MR imaging features of subacute combined degeneration patients.

Authors:  Hye Young Sun; Joon Woo Lee; Kyung Seok Park; Jae Yeon Wi; Heung Sik Kang
Journal:  Eur Spine J       Date:  2014-01-28       Impact factor: 3.134

Review 2.  Recreational Nitrous Oxide Abuse: Prevalence, Neurotoxicity, and Treatment.

Authors:  Yuanyuan Xiang; Lei Li; Xiaotong Ma; Shan Li; Yuan Xue; Peng Yan; Meijie Chen; Junwei Wu
Journal:  Neurotox Res       Date:  2021-03-26       Impact factor: 3.911

Review 3.  Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review.

Authors:  Sanad Oulkadi; Benjamin Peters; Anne-Sophie Vliegen
Journal:  J Thromb Thrombolysis       Date:  2022-06-27       Impact factor: 2.300

4.  The Effect of Vitamin B12 Infusion on Prevention of Nitrous Oxide-induced Homocysteine Increase: A Double-blind Randomized Controlled Trial.

Authors:  Alieh Zamani Kiasari; Abolfazl Firouzian; Afshin Gholipour Baradari; Hamid Sharif Nia; Seyed Hosein Moosavi Kiasari
Journal:  Oman Med J       Date:  2014-05

5.  Subacute combined degeneration of the spinal cord following recreational nitrous oxide use.

Authors:  Hui Mei Cheng; Jae Hong Park; David Hernstadt
Journal:  BMJ Case Rep       Date:  2013-03-08

Review 6.  Volatile substance misuse: an updated review of toxicity and treatment.

Authors:  Jonathan B Ford; Mark E Sutter; Kelly P Owen; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

7.  Assessment of reinforcement enhancing effects of toluene vapor and nitrous oxide in intracranial self-stimulation.

Authors:  Matthew E Tracy; Galina G Slavova-Hernandez; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2013-11-02       Impact factor: 4.530

8.  Rapidly progressive dementia and ataxia in an elderly man.

Authors:  Rebekah M Ahmed; G Michael Halmagyi; Michael L Rodriguez
Journal:  Pract Neurol       Date:  2013-03-13

9.  The neurotoxicity of nitrous oxide: the facts and "putative" mechanisms.

Authors:  Sinead Savage; Daqing Ma
Journal:  Brain Sci       Date:  2014-01-28

10.  Neuropsychiatric Symptoms Induced by Large Doses of Nitrous Oxide Inhalation: A Case Report.

Authors:  Tianzhen Chen; Na Zhong; Haifeng Jiang; Min Zhao; Zhikang Chen; Haiming Sun
Journal:  Shanghai Arch Psychiatry       Date:  2018-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.